MECHANISMS OF SIGNAL TRANSDUCTION
RGS12 and RGS14 GoLoco Motifs Are GαiInteraction Sites with Guanine Nucleotide Dissociation Inhibitor Activity*

https://doi.org/10.1074/jbc.M103208200Get rights and content
Under a Creative Commons license
open access

The regulators of G-protein signaling (RGS) proteins accelerate the intrinsic guanosine triphosphatase activity of heterotrimeric G-protein α subunits and are thus recognized as key modulators of G-protein-coupled receptor signaling. RGS12 and RGS14 contain not only the hallmark RGS box responsible for GTPase-accelerating activity but also a single Gαi/o-Loco (GoLoco) motif predicted to represent a second Gα interaction site. Here, we describe functional characterization of the GoLoco motif regions of RGS12 and RGS14. Both regions interact exclusively with Gαi1, Gαi2, and Gαi3 in their GDP-bound forms. In GTPγS binding assays, both regions exhibit guanine nucleotide dissociation inhibitor (GDI) activity, inhibiting the rate of exchange of GDP for GTP by Gαi1. Both regions also stabilize Gαi1 in its GDP-bound form, inhibiting the increase in intrinsic tryptophan fluorescence stimulated by AlF 4. Our results indicate that both RGS12 and RGS14 harbor two distinctly different Gα interaction sites: a previously recognized N-terminal RGS box possessing Gαi/o GAP activity and a C-terminal GoLoco region exhibiting Gαi GDI activity. The presence of two, independent Gα interaction sites suggests that RGS12 and RGS14 participate in a complex coordination of G-protein signaling beyond simple Gα GAP activity.

Cited by (0)

Published, JBC Papers in Press, May 31, 2001, DOI 10.1074/jbc.M103208200

*

This work was supported by National Institutes of Health Grants GM62338 (to D. P. S.), CA58689, and DK17780 (to M. G. F.).

Supported in part by NIDDK, National Institutes of Health (NIH), Grant DK07386 and NIGMS, NIH, Grant GM07040.

A Year 2000 Scholar of the EJLB Foundation and recipient of a Burroughs Wellcome Fund New Investigator Award in the Basic Pharmacological Sciences. To whom all correspondence should be addressed: Dept. of Pharmacology, CB#7365, UNC-Chapel Hill School of Medicine, Mary Ellen Jones Bldg., Rm. 1106, Chapel Hill, NC 27599-7365. Tel.: 919-843-9363; Fax: 919-966-5640; E-mail: [email protected].